TribLIVE

| USWorld

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Aspirin use tied to age-related vision loss

Email Newsletters

Click here to sign up for one of our email newsletters.

Daily Photo Galleries

'American Coyotes' Series

Traveling by Jeep, boat and foot, Tribune-Review investigative reporter Carl Prine and photojournalist Justin Merriman covered nearly 2,000 miles over two months along the border with Mexico to report on coyotes — the human traffickers who bring illegal immigrants into the United States. Most are Americans working for money and/or drugs. This series reports how their operations have a major impact on life for residents and the environment along the border — and beyond.

By Reuters
Sunday, Jan. 27, 2013, 5:56 p.m.
 

Taking at least one aspirin every week is linked to the development of age-related vision loss, according to an Australian study that looked at information collected over 15 years.

More than 100 billion aspirin tablets are consumed every year, commonly in the prevention of heart attacks or strokes.

In 2011, a European study found that seniors who took a daily aspirin were twice as likely to develop vision loss such as macular degeneration, compared with those who did not — prompting new study leader Jie Jin Wang into trying to confirm its findings.

Overall, Wang, from the University of Sydney, and her colleagues had information on 2,389 people older than 45. Of those, 257 said they took at least one aspirin every week.

By the end of the study, 63 people had developed so-called wet macular degeneration, the most severe form. A total of 5.8 percent of regular aspirin users developed the vision loss, compared with 2.3 percent of people who did not regularly take aspirin.

“Regular aspirin use is associated with increased risk of incident neovascular (wet) age-related macular degeneration, independent of a history of cardiovascular disease and smoking,” Wang and her colleagues wrote.

They warned, though, that there's still not enough evidence to say taking aspirin leads to the condition.

But in a commentary published with the study, Sanjay Kaul and George Diamond cautioned that the study had limitations, noting that previous studies had found mixed results when looking at aspirin use and vision loss.

They wrote that the evidence was not convincing enough for doctors to change how they prescribe aspirin, especially with its benefits in preventing heart attack and stroke.

“In the final analysis, decisions about aspirin use are best made by balancing the risks against the benefit in context of each individual's medical history and value judgment,” they wrote.

Wang agreed that the findings are not strong enough to support a change in clinical practice, but she said some doctors may want to keep a closer watch on patients at higher risk for macular degeneration who are using aspirin.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. Cincy officer indicted on murder charge in fatal shooting of motorist
  2. Clinton to testify before House committee on Benghazi in October
  3. Cruz chided over remarks in prelude to Ex-Im Bank vote
  4. Planned Parenthood requests expert study
  5. Undocumented alien released, suspected in crime spree
  6. University of New Hampshire language guide panned
  7. Feds accuse Philadelphia congressman Fattah of corruption
  8. Calif. oil slick expected to dissipate
  9. Cruz switches targets, takes exception with IRS practices
  10. VA health system short 41K physicians
  11. Minn. man accused of slaying protected Zimbabwean lion says he thought the trip was legal